Tag

cancer

Browsing

Government of Nigeria Announces New Anti-Cancer Policies

The Nigerian government has launched new policies to tackle non-communicable diseases (NCDs) which are responsible for a significant number of deaths in the country.

Summary

  • The Nigerian government has launched six policy documents focused on the prevention and control of Non-communicable Diseases (NCD) such as cancer, respiratory diseases, diabetes and mental health disorders.
  • These conditions account for 27 percent of all annual deaths in Nigeria, equating to approximately 447,800 lives lost each year.
  • Unhealthy lifestyles such as tobacco use, alcohol consumption, poor diets, and physical inactivity are important factors contributing to these NCDs.
  • The new policies include guidelines for hypertension management and tobacco control. The government also plans to expand infrastructure for cancer treatment and train health workers.
Government of Nigeria Announces New Anti-Cancer Policies
Background with flag of Nigeria

Nigeria’s Bold Move Against Non-Communicable Diseases

Non-communicable diseases (NCDs) have been silently harming Nigeria. They take hundreds of thousands of lives each year. The Nigerian government wants to fight this problem. They have introduced six new policies. These policies aim to prevent and control these diseases. This is a big and important change in Nigeria’s healthcare system.

NCDs, such as cancer, respiratory diseases, diabetes, and mental health disorders, have become a major public health concern in Nigeria. These conditions account for a staggering 27% of all annual deaths, making them a leading cause of mortality. The alarming statistics highlight the urgent need for effective interventions.

A number of factors contribute to the high prevalence of NCDs in Nigeria. Unhealthy lifestyles, including tobacco use, excessive alcohol consumption, poor diets, and physical inactivity, play a significant role. These behaviors increase the risk of developing chronic diseases and can exacerbate existing health conditions.

In recognition of the gravity of the NCD crisis, the Nigerian government has developed a comprehensive set of policies to address the issue. These policies focus on prevention, early detection, and effective management of NCDs. Some of the key components of the government’s strategy include:

  • Expanding access to healthcare: The government plans to increase the availability of quality healthcare services, particularly in rural areas, to ensure that everyone has access to preventive care and treatment.
  • Promoting healthy lifestyles: Public health campaigns will be launched to encourage healthy behaviors, such as regular physical activity, balanced diets, and tobacco cessation.
  • Strengthening healthcare infrastructure: Investments will be made to improve the capacity of hospitals and clinics to diagnose and treat NCDs.
  • Training healthcare professionals: Healthcare workers will receive training on the prevention, diagnosis, and management of NCDs.
  • Implementing tobacco control measures: Stricter regulations will be introduced to reduce tobacco consumption and exposure.

The battle against NCDs is complicated. NCDs are non-communicable diseases like heart disease and diabetes. But with a comprehensive and coordinated approach, Nigeria can make significant progress. Comprehensive means covering all aspects. Coordinated means working together in harmony. The government’s new policies offer hope. These policies aim for a healthier future for the nation.

#Nigeria, #NCDs, #publichealth, #healthcare, #healthpolicy, #cancer, #diabetes, #heartdisease, #tobaccocontrol, #healthyeating, #physicalactivity, #prevention, #treatment, #accesshealthcare, #healthcareinfrastructure, #healthprofessionals, #Government of Nigeria

Triple-Negative Breast Cancer – TNBC

Triple-negative breast cancer is characterized by the absence of estrogen receptors, progesterone receptors, and an overabundance of human epidermal growth factor (HER2) protein.

These findings indicate that the cancer’s growth is not driven by the hormones estrogen and progesterone, nor by the HER2 protein. As a result, this cancer does not react to hormone therapy or medications that target the HER2 protein receptor. Other medications, however, are used to successfully treat the breast cancer.

Consider cancer cells to be like a house. The front door may be equipped with three types of locks, referred to as receptors: estrogen, progesterone, and HER2. There are a few keys that doctors can use to help eliminate cancer cells if your cancer has any of these three locks. These keys include hormone treatment and other medications, which can be used to assist destroy the cancer cells.

However, if you have triple-negative breast cancer, this means that none of the three locks are present in your tumor. As a result, doctors have fewer therapy options available to them. Though, chemotherapy is still a viable treatment option.

most cancer cells vs triple-negative breast cancer cells
most cancer cells vs triple-negative breast cancer cells

This cancers account for around 10-20 percent of all breast cancers. Doctors and researchers are extremely interested in discovering new treatments that can be used to treat this particular type of breast cancer. In order to determine if certain treatments can impact with the processes that enable this kind of breast cancer to grow, researchers are conducting studies.

Read Also:

Learning all about cancer | World Breast Cancer day

Hormonal treatment drugs, such as tamoxifen and aromatase inhibitors, are unlikely to help the cancer. Additionally, it is unlikely to respond to medications that affect the HER2 protein, such as Enhertu (fam-trastuzumab-deruxtecan-nxki), Herceptin (trastuzumab), Kadcyla (T-DMA or ado-trastuzumab emtansine), Nerlynx (neratinib), Perjeta (pertuzumab), or Tykerb (chemical name: lapatinib).

Because there are fewer specific treatments available to this kind of breast cancer, it is thought to be more aggressive and have a worse prognosis than other kinds of breast cancer. This cancer has been demonstrated in studies to be more likely to spread outside the breast and to relapse (return) after therapy.

It has a higher prognosis than other forms of breast cancer. In terms of appearance and growth patterns, the higher the grade, the less cancer cells resemble normal, healthy breast cells. Triple-negative breast cancer is usually grade 3 on a scale of 1 to 3.

Who is at risk of developing triple-negative breast cancer?

  • Women under the age of 40, who are African-American, or who have a BRCA1 genetic mutation are more likely to get these cancers.
  • People under the age of 50 are more likely to be diagnosed with triple-negative breast cancer. People over the age of 60 are more likely to be diagnosed with other kinds of breast cancer.
  • Compared to women of other races, triple negative/basal-like tumors appear to be more common in Black, non-Hispanic Black, and African American women (particularly before menopause) [53,55-58].

If you’ve been told you have triple-negative breast cancer.

Finding out you have a kind of breast cancer that is generally more aggressive than other varieties and isn’t a good candidate for hormone receptor or HER2 protein-targeted therapy can be frustrating and frightening.

It’s crucial to remember, however, that the lack of hormone receptors and high HER2 protein are just two of the aspects that you and your doctor will examine when deciding on a treatment strategy. Your prognosis is also influenced by the cancer’s stage and grade.

It’s also crucial to keep in mind that there are treatments for this type of cancer.

Treatment

Surgery, radiation therapy, and chemotherapy are common treatment options for cancer patients.

Immunotherapy Treatment Option

Immunotherapy medications target cancer cells by harnessing the power of your body’s immune system.

Keytruda (chemical name: pembrolizumab) is an immunotherapy drug used to treat triple-negative breast cancer.

Keytruda is a drug that is used in combination with chemotherapy to treat triple-negative, PD-L1-positive breast cancer that is unresectable locally progressed or metastatic.

The term “unresectable” refers to a cancer that cannot be removed through surgery.

Keytruda is also used to treat early-stage triple-negative breast cancer with a high risk of recurrence in conjunction with chemotherapy before surgery and then on its own following surgery (the cancer coming back).

Neoadjuvant chemotherapy Treatment option

When this type of cancer is treated with chemotherapy before surgery — known as neoadjuvant chemotherapy — when there is a pathologic complete response, research has shown that disease-free survival and overall survival are improved.

Looking at the tissue removed during surgery to see if any active cancer cells are present is one approach for clinicians to measure the effectiveness of neoadjuvant treatment. A “pathologic complete response,” or pCR, occurs when there are no active cancer cells present.

The term “disease-free survival” refers to how long a person can go without their cancer reappearing. Overall survival refers to how long a person lives after a cancer diagnosis, regardless of whether or not the disease recurs.

PARP inhibitors treatment option

PARP inhibitors like Lynparza (olaparib) and Talzenna (talazoparib) have been approved for the treatment of advanced-stage HER2-negative breast cancer in persons with a BRCA1 or BRCA2 mutation.

In both healthy and malignant cells, the poly ADP-ribose polymerase (PARP) enzyme repairs DNA damage. Medicines that interfere with or suppress the PARP enzyme make it much more difficult for cancer cells with a BRCA1 or BRCA2 mutation to repair DNA damage, according to research. The cancer cells have a tougher time surviving as a result of this. In other words, a PARP inhibitor reduces the likelihood of some cancer cells surviving DNA damage.

What is the survival rate of triple-negative breast cancer?

It is estimated that 91 percent of women will survive five years after being diagnosed with locally advanced triple-negative breast cancer, which means the cancer has not progressed outside of the breast (91 percent as likely as someone without cancer to survive during the five-year period). Cancer that has spread to surrounding lymph nodes or other nearby locations has a five-year survival rate of 65 percent when it first appears. Cancer that has spread to other parts of the body, such as the bones, lungs, or liver, has a survival rate of 11 percent or lower.

Survival rates are calculated as averages based on what has occurred in the past. The outlook for cancer patients may improve as research and cancer therapy progress.

According to the SEER database, which is maintained by the National Cancer Institute, these figures do not distinguish between stages of cancer or take into consideration variables such as patient age and overall health.

Is triple-negative cancer bad?

TNBC is classified as an aggressive disease because it grows quickly, is more likely to have spread at the time of diagnosis, and is more likely to recur after therapy than other types of breast cancer. The prognosis for this type of breastcancer is not as good as it is for other types.

How long is chemo for triple-negative breast cancer?

Twelve weeks of taxol is followed by four doses of adriamycin and cytoxan in a conventional triple-negative chemo regimen. Doctors gave participants an additional chemo medication called carboplatin in the new study. According to the study, 54 percent of women who took carboplatin were successful, compared to only 40 percent of women who did not take carboplatin. However, because to carboplatin’s high toxicity, several women were unable to take it and had to end their chemotherapy treatment early.

Is TNBC a death sentence?

TNBC does not constitute a death sentence! Patients should be informed that there are effective treatments for this condition and that they have a chance of surviving. Make a point of mentioning that TNBC is highly responsive to chemotherapy and that a large number of clinical trials are possible if normal treatment becomes unsuccessful.

Can triple-negative breast cancer be cured?

Dr. Jacoub believes that triple-negative breast cancer is treatable if it is discovered during the first three stages (1–3) of the disease. He uses every tool available to him to treat stages 1–3 cancer in order to completely eradicate and kill it.

But the capacity to treat triple-negative breastcancer is hampered by the presence of recurrence or metastasis beyond the lymph nodes of the patient. Triple-negative breast cancer is the type of breast cancer that is most likely to recur after treatment.

Over a 5-year period, the prognosis for persons with locally advanced triple-negative breastcancer is favorable. Approximately 91 percent of persons will make it to the 5-year milestone in their lives.

Those who have cancer that has progressed to local tissue or lymph nodes have a 5-year survival rate of only 65 percent. Upon spreading to other organs or tissues, the mortality rate drops to 12 percent from the initial figure.

These figures are based on data collected from patients who have previously received treatment. Newer approaches have altered the picture, which is expected to continue to vary as new therapies become available in the future.

Dr. Nan has anecdotally observed a subset of patients who have responded to immunotherapy treatment for a period of more than five years.

“Perhaps if his practice follows these patients for a long enough period of time, some of them may still be alive after more than 10 or 15 years, we will be able to declare their cancer healed,” he speculated. “In the future, we may be able to cure stage 4 cancer with immunotherapies that have been created or that are newer.”

Dr. Jacoub acknowledged that emerging treatments are altering the outlook for the future. He further stated that, while some patients experience a diminished quality of life while having therapy, others might maintain a high level of well-being throughout the process.

Is triple negative hereditary?

Researchers from the University of Southampton and colleagues from around the world tested DNA samples donated by 1824 women with triple negative breast cancer for mutations in 17 genes that have been linked to breast cancer in a study that was partially funded by Breast Cancer Campaign in order to learn more about the genetics of triple negative breastcancer. This is the broadest analysis on breast cancer gene mutations in triple negative breast cancer that has been conducted to date.

The findings, which were published revealed that 14.5 percent (167) of the triple negative patients had genetic abnormalities that were passed down via their families. The mutations were detected in 14 of the 17 genes under investigation, with the BRCA1 (155 mutations found) and BRCA2 (49 mutations found) genes exhibiting the highest frequency of alterations. A genetic mutation also increased the likelihood of being detected at a younger age, with the average age at diagnosis being 45 years old, compared to 52 for women who did not have mutations.

In addition, many of the women who had a genetic mutation did not have a family history of breast or ovarian cancer. This was especially true for women who had a mutation in a gene other than the BRCA genes.

How long can you live with metastatic TNBC?

TNBC has been demonstrated to have a bad prognosis in the majority of cases. Death rates are highest among all subtypes of breastcancer within the first 3-5 years of diagnosis, despite the fact that late relapses are less common. TNBC is a highly diverse malignancy, and the prognosis for each individual patient can be extremely variable. TNBC that has spread throughout the body is generally regarded as incurable. Patients with metastatic disease had a median survival duration of approximately 9 months, compared to a survival period of 20 months for patients with other subtypes of breast cancer. Patient’s with metastatic TNBC have a median survival period of approximately 13 months on average.

While new targeted medicines are being developed for breast cancer, there are presently no effective targeted therapies available for individuals with triple-negative breast cancer (TNBC). As an additional point of interest, there are only a few published studies in the literature that detail long-term full remissions in patients with metastatic TNBC.

Sources:

  1. American Cancer Society. Triple-negative breast cancer
  2. Breastcancer.org. Triple-Negative Breast Cancer
  3. National Cancer Institute. FDA Approves Pembrolizumab for Certain Patients with Triple-Negative Breast Cancer
  4. ClinicalTrials.gov. Olaparib and Talazoparib for Advanced TNBC With Germline BRCA Mutations
  5. sciencedirect. Androgen Receptor Expression May Predict Response to PARP Inhibitors in TNBC
  6. National Institutes of Health. Liquid biopsy for minimal residual disease detection in breast cancer
  7. Nature Reviews Cancer. Gene-expression-based prognostic assays for breast cancer

Learning all about Cancer | World Breast Cancer day

What Is Cancer?

Cancer is a general word for a group of diseases characterized by the growth and invasion of healthy cells in the body by malignant cells. Breast cancer begins as a cluster of cancer cells in the breast’s cells, which can subsequently infiltrate surrounding tissues or migrate to other parts of the body (metastasize).

What Causes Cancer to Form?

Cancer starts in the cells, which are the fundamental components of tissue. The breast and other areas of the body contain tissue. When the cell growth process goes bad, new cells form when the body doesn’t require them, and old or damaged cells do not die as they should. When this happens, a mass of tissue known as a lump, growth, or tumor emerges as a result of the buildup of cells.

When malignant tumors develop in the breast, it is called breast cancer. These cells can spread throughout the body by breaking away from the primary tumor and entering blood arteries or lymph vessels, which branch out into various regions. The process of cancer cells spreading to other parts of the body and causing damage to other tissues and organs is known as metastasis.

Learning all about cancer , World Breast Cancer day

Causes of Breast Cancer

After being diagnosed with breast cancer, it’s normal to ask what went wrong. However, no one is aware of the precise causes of this disease. Doctors aren’t sure why one woman gets breast cancer while another does not, and most women with breast cancer will not know the exact origin of their disease. While the exact etiology(exact cause) of breast cancer is unknown, damage to a cell’s DNA is always thought to be a factor in its development.

Risk Factors That Have Been Recognized

Breast cancer is more common in women who have certain risk factors than in women who do not. A risk factor is anything that increases the likelihood of contracting a disease. Some risk factors, such as alcohol consumption, can be prevented. However, the majority of risk factors (such as a family history of the disease) are unavoidable. Having a risk factor for breast cancer does not guarantee that a woman will develop the disease. Many women with risk factors for breast cancer never experience the disease.

What is Known so far

Breast cancer is more common cancer among women globally, taking the lives of hundreds of thousands of women every year impacting countries at all levels of development, according to the World Health Organization.

In recent years, probably as a result of a decrease in the use of prescription hormone replacement medication after menopause, we have noticed a progressive decrease in the incidence of female breast cancer among women aged 50 and older. It has been almost 20 years since the death rate from breast cancer has decreased, in part due to improved screening and early identification, more public awareness, and ever improving treatment choices.

What Exactly Is A Tumor?

A tumor is an abnormal tissue mass. Breast cancer tumors are classified as either benign or malignant, depending on whether they are non-cancerous or cancerous.

Benign Tumors

When a tumor is determined to be benign, it will most likely be left alone by doctors rather than being surgically removed. But even if they don’t attack the surrounding tissue, these tumors can continue to grow and put pressure on it, leading to discomfort or other issues. When this occurs, the tumor is removed, which alleviates the patient’s symptoms.

Malignant tumors

Malignant tumors are cancerous and can be aggressive in their invasion and destruction of surrounding tissue due of their cancerous nature. Whenever a tumor is considered to be malignant, a biopsy will be performed by a doctor to determine the severity and aggressiveness of the tumor.

Metastatic cancer

When cancer cells from a malignant tumor move to other parts of the body, usually through the lymph system or the bloodstream, and form a secondary tumor, it is known as metastatic cancer.

Breast Cancer in Male (Breast Cancer men)

Male or female, are born with some amount of breast cells and tissue. Despite the fact that males do not grow milk-producing breasts, the cells and tissue of a man’s breasts can nonetheless develop cancer. Male breast cancer, on the other hand, is extremely rare. Men account for less than one percent of all breast cancer cases, and just one in every thousand men will be diagnosed with breast cancer at some point in their lives.

A firm lump beneath the nipple and areola is frequently the first sign of breast cancer in men. Men have a greater mortality rate than women, owing to a lack of awareness and a lower likelihood of mistaking a bump for breast cancer, which can lead to a delay in seeking treatment. Men over the age of 50 make up the bulk of those diagnosed.

Risk Factors of breast cancer in men

  1. Exposure to radiation.
  2. Estrogen levels that are too high.
  3. Breast cancer in the family, particularly breast cancer linked to the BRCA2 gene.

Signs and Symptoms of breast cancer in male

Male breast cancer might have the same signs as female breast cancer, such as a lump. Anyone who discovers anything strange about their breasts, male or female, should see their doctor right once.

In the shower, most guys discover their own lump, which is commonly found beneath the nipple and areola. Men frequently put off reporting a bump to a doctor, which might lead to the patient needing further therapy.

Men’s breast cancer is estrogen receptor positive in nearly all cases, and 70 percent of women’s breast cancer is estrogen receptor positive as well. Men with breast cancer have similar survival rates and treatment options as women. Breast cancer can be detected early, which expands treatment options and lowers the risk of dying from the disease.

Breast cancer Treatment

Surgery, radiation, hormone therapy, chemotherapy, and targeted therapies are the five therapeutic options available in general, and most treatment plans comprise a combination of them. Some are local, focusing on the tumor’s immediate surroundings. Others are systemic, utilizing cancer-fighting substances throughout your entire body.

Surgery

Surgery is the most common treatment for breast cancer. This entails removing the tumor as well as the surrounding margins. A lumpectomy, partial mastectomy, radical mastectomy, and reconstruction are all surgical alternatives.

Mastectomy

In the past, breast cancer surgery frequently necessitated the removal of the entire breast, chest wall, and all axillary lymph nodes in a technique known as a radical mastectomy, which was a major undertaking. Despite the fact that radical mastectomies are becoming less common, there are still circumstances in which this surgery is the best option for treating breast cancer.

If breast cancer is discovered early enough, there are often treatment options available that will remove the disease while leaving the breast tissue intact. A lumpectomy (which is most typically followed by breast radiation treatments) and a partial mastectomy are the most prevalent therapeutic choices.

Partial Mastectomy

In order to eliminate the malignancy, a partial mastectomy necessitates the surgeon removing a bigger amount of the breast than a lumpectomy — maybe an entire section of tissue. The surgeon may also remove some of the lining around the chest muscles on occasion.

Skin-Sparing Mastectomy

The breast, nipple, areola, and sentinel lymph node (or nodes) are all removed during this treatment, but not the breast skin. This treatment is chosen by many women who want to get breast reconstruction.

Simple Mastectomy (also called total mastectomy)

The breast, nipple, areola, and sentinel lymph node or nodes must all be removed during this procedure. The chest wall and more distant lymph nodes are unaffected.

Modified Radical Mastectomy

The entire breast, nipple, areola, and axillary lymph nodes are removed during this treatment, although the chest wall is generally left intact.

Lumpectomy

When having a lumpectomy, your doctor will remove only what is necessary to eliminate the tumor, plus a small amount of healthy breast tissue around it. But only a little margin of healthy tissue around the affected area is removed by the surgeon. However minimally invasive lumpectomies are, they can still be highly effective, and additional surgery may not be required in some cases.

Removal of Lymph Node  & Lymphedema

To find out if and how far the cancer has spread, your doctor may have to remove and check lymph nodes. A sentinel lymph node biopsy or removal will be used by your doctor, or an axillary node dissection.

What is a sentinel lymph node biopsy

A sentinel lymph node biopsy is a procedure that examines the lymph node nearest to the tumor, as this is the most likely location for cancer cells to disseminate. To begin, the surgeon will seek to identify the “sentinel lymph node,” which refers to the lymph node (or nodes) that are closest to the tumor. The surgeon will inject dye or radioactive substances into the tissue near the tumor in order to detect the sentinel lymph node. The dye or radioactive chemical will be used to mark the lymph nodes that are more susceptible to cancer spread. The adjacent lymph nodes will be excised and examined for the presence of cancer cells during surgery.

What is Axillary Node Dissection

This treatment is used to determine if the cancer has progressed to more than one of your lymph nodes, which can be dangerous. Axillary node dissection is a procedure that involves the removal of some of the axillary lymph nodes, which are lymph nodes located in the underarm area. Once they have been removed, they are dissected and analyzed by a pathologist, who examines all of the tissue and individual nodes under a microscope in great detail.

Breast Reconstruction

Your age, body type and treatment plan will all play a role in determining which of several breast reconstruction alternatives you choose.

1. Breast Implants: Saline or silicone gel or a combination of the two are used to fill the breasts.

2. Another option is to use tissue from your belly (TRAM), back (latissimus), or buttocks, which the surgeon extracts during surgery (gluteal). This tissue is sculpted by the surgeon to take on the contour of your breasts. (aka Skin Graft)

What Is Lymphedema

When the lymph nodes are damaged or disrupted, it results in lymphedema, which is a chronic illness that can last for years. It is most commonly associated with arm swelling, but it can also manifest itself in the breast, chest, and, in rare cases, the legs. Lymphedema is a type of swelling that develops as a result of an improper accumulation of too much fluid. Removing the axillary lymph nodes raises your chances of acquiring lymphedema in the long run.

Because the risk of developing lymphedema persists for the rest of your life, it is critical that you are aware of these dangers. It is often preferable to learn about lymphedema prevention measures before having surgery so that you will be aware of the signs and symptoms to check for and can discuss treatment options with your doctor before having surgery.

What Is Chemotherapy?

Chemotherapy is a type of treatment that employs a cocktail of medications to either kill or halt the growth of cancer cells.

  • Chemotherapy is a systemic treatment, which implies the medicine travels throughout the body via the bloodstream.
  • Cytotoxic medicines are typically administered orally or by a vein (intravenously or “into the bloodstream”). The word Cytotoxic means its toxic to cells

Who Requires Chemotherapy for Breast Cancer?

Chemotherapy is recommended for the majority of patients for a variety of reasons, including the following:

  • Type of tumor.
  • Grade of tumor.
  • Size of the tumor.
  • The type and state of the receptors.
  • The number and extent of lymph nodes involved.
  • The possibility of cancer spreading to other parts of the body.

How Is Chemotherapy for Breast Cancer Administered?

When combined with other treatment modalities such as hormonal and targeted medicines, chemotherapy is a typical treatment option offered. The term “neoadjuvant chemotherapy” describes the use of chemotherapy to reduce a tumor prior to surgery in order to make removal easier and safer.

The chemotherapy will be administered in short courses with several weeks between each to allow your normal cells to recover. If you are given chemotherapy, your physician will administer it in short durations with several weeks between each to allow your normal cells to recover. This therapy period can be a difficult time for the patient, both mentally and physically. It is critical for you to put together a support group of relatives or friends who can offer comfort and encouragement to you during this difficult time.

What Are Chemotherapy’s Side Effects?

Although chemotherapy is effective in killing quickly dividing cancer cells, the medications can, unfortunately, cause harm to normal cells that divide at a rapid rate as well.

  • It’s possible that your red blood cell count will drop. You’re more prone to have infections, bruise or bleed easily, and feel very weak and exhausted when medications diminish the levels of healthy blood cells. Low blood cell levels will be checked by your medical staff.
  • It’s possible that your white blood cell count will drop. A decrease in white blood cells can make you more susceptible to infection. This is why it’s critical to avoid people who have the flu or a cold, eat healthy meals, get enough of rest, and take your temperature every day. A rise in body temperature is frequently the first indicator of neutropenia, or a lack of white blood cells.
  • Chemotherapy has the potential to harm hair-producing cells. Chemotherapy has the potential to cause hair loss. Hair will regrow following treatment if you lose it, although the coloring and textures may be altered.
  • A changing balance of cells lining your intestinal system may cause alterations. Chemotherapy can induce nausea, vomiting, diarrhea, and mouth and lip sores, among other things.
  • Chemotherapy has the potential to harm nerve cells. Some breast cancer medications might induce tingle or numbness in the hands or feet, which can be very uncomfortable.

Is there any long-term negative effect of chemotherapy?

People do occasionally have challenges that may or may not resolve themselves. Some of the medications used to treat breast cancer, for example, have been shown to weaken the heart. Before, during, and after treatment, your doctor may want to check on your heart. A rare adverse effect of chemotherapy is the development of leukemia (cancer of the blood cells) in a small number of women, sometimes years after treatment has been completed .

Some chemotherapy medications have been shown to cause ovarian harm. It is possible to experience hot flashes and vaginal dryness even if you have not yet entered menopause. It is possible that your menstrual periods have become irregular or have completely stopped. It is possible that you will become sterile (unable to become pregnant).

Breast cancer month (World Breast Cancer Day)

Every year on October 19, the World Breast Cancer Day is commemorated.

Sources:

  • American Cancer Society.  “Breast Cancer.” Link
  • World Health Organization. “Breast cancer: prevention and control.” Link